Company Filing History:
Years Active: 2024
Title: Simon Ametamey: Innovator in Radiopharmaceuticals
Introduction
Simon Ametamey is a distinguished inventor based in Zurich, Switzerland. He has made significant contributions to the field of radiopharmaceuticals, particularly in the development of isomerically pure F-labelled tetrahydrofolates. His work is pivotal in advancing diagnostic imaging techniques for various medical conditions.
Latest Patents
Ametamey's notable patent is titled "Isomerically pure F-labelled tetrahydrofolates." This invention focuses on creating isomerically pure F-labelled (6S)- or (6R)-5-methyltetrahydrofolate radiopharmaceuticals. The innovation involves replacing the phenyl group within the folate structure with an F-labelled N-heterocycle. This advancement is intended for use in diagnostic imaging of cells expressing a folate receptor, both in vitro and in vivo, and for monitoring cancer, inflammatory, and autoimmune diseases.
Career Highlights
Throughout his career, Simon Ametamey has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Patent GmbH and Piramal Imaging SA, where he has contributed to various innovative projects. His expertise in radiopharmaceuticals has positioned him as a key figure in the field.
Collaborations
Ametamey has collaborated with notable professionals, including Rudolf Moser and Viola Groehn. These partnerships have further enhanced his research and development efforts in the realm of medical imaging.
Conclusion
Simon Ametamey's contributions to the field of radiopharmaceuticals exemplify his commitment to innovation and medical advancement. His work continues to impact diagnostic imaging and therapeutic monitoring, showcasing the importance of his inventions in modern medicine.